Evaluation of anti-Müller hormone AMH levels in obese women after sleeve gastrectomy

Gynecol Endocrinol. 2019 Jun;35(6):548-551. doi: 10.1080/09513590.2018.1559285. Epub 2019 Jan 22.

Abstract

Introduction: The link between obesity epidemic in fertile age and fertility reduction, in relation with BMI increase, has been demonstrated. An inverse proportionality between BMI and anti-Müller hormone (AMH) has been investigated. This hormone is strictly related to ovarian function. It has been demonstrated that it is significantly decreased in obese women.

Scope: The aim of this study was evaluation of AMH levels in 53 obesity women with BMI >35, at 3 and 6 months after laparoscopic sleeve gastrectomy (LSG). Specific evaluation of comorbidities and of gynecological effects of weight loss was also evaluated.

Results: Cohort of 53 women was considered, treated with LSG. A progressive increase of AMH levels after LSG was confirmed, with statistically significant results at followup of 6 months. In these patients, we also observed an improvement in the menstrual cycle and resolution of dysmenorrhea. All considered comorbidities were ameliorated at both followup.

Conclusion: LSG determined a significant increase of AMH level in women, at early followup, with a comprehensive amelioration of gynecological status. Larger cohorts and a better evaluation of ovarian function after LSG will lead to more powerful results of the effect of weight loss on women.

Keywords: Obesity; anti-Müller hormone (AMH); dysmenorrhea; infertility; sleeve gastrectomy.

MeSH terms

  • Adult
  • Anti-Mullerian Hormone / blood*
  • Body Mass Index
  • Female
  • Gastrectomy*
  • Humans
  • Obesity / blood*
  • Obesity / surgery*
  • Postoperative Period
  • Treatment Outcome
  • Weight Loss / physiology
  • Young Adult

Substances

  • Anti-Mullerian Hormone